Software - Application
Compare Stocks
2 / 10Stock Comparison
MYSE vs ANGI
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
MYSE vs ANGI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Internet Content & Information |
| Market Cap | $6M | $192M |
| Revenue (TTM) | $581.00 | $1.02B |
| Net Income (TTM) | $-5M | $20M |
| Gross Margin | -3631.6% | 91.1% |
| Operating Margin | -9397.7% | 4.8% |
| Forward P/E | — | 5.6x |
| Total Debt | $0.00 | $498M |
| Cash & Equiv. | $1M | $304M |
MYSE vs ANGI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 21 | May 26 | Return |
|---|---|---|---|
| Myseum Inc. (MYSE) | 100 | 2.7 | -97.3% |
| Angi Inc. (ANGI) | 100 | 4.5 | -95.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MYSE vs ANGI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MYSE is the clearest fit if your priority is long-term compounding.
- -94.1% 10Y total return vs ANGI's -94.5%
- -17.9% vs ANGI's -57.4%
ANGI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.85
- Rev growth -13.0%, EPS growth 32.4%, 3Y rev CAGR -16.4%
- Lower volatility, beta 1.85, Low D/E 53.7%, current ratio 1.65x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -13.0% revenue growth vs MYSE's -35.1% | |
| Quality / Margins | 1.9% margin vs MYSE's -8.2K% | |
| Stability / Safety | Beta 1.85 vs MYSE's 2.34 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -17.9% vs ANGI's -57.4% | |
| Efficiency (ROA) | 1.2% ROA vs MYSE's -70.0%, ROIC 5.0% vs -90.3% |
MYSE vs ANGI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MYSE vs ANGI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ANGI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ANGI is the larger business by revenue, generating $1.0B annually — 1760364.9x MYSE's $581. ANGI is the more profitable business, keeping 1.9% of every revenue dollar as net income compared to MYSE's -8154.6%. On growth, MYSE holds the edge at +4.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $581 | $1.0B |
| EBITDAEarnings before interest/tax | -$5M | $86M |
| Net IncomeAfter-tax profit | -$5M | $20M |
| Free Cash FlowCash after capex | -$4M | $26M |
| Gross MarginGross profit ÷ Revenue | -3631.6% | +91.1% |
| Operating MarginEBIT ÷ Revenue | -9397.7% | +4.8% |
| Net MarginNet income ÷ Revenue | -8154.6% | +1.9% |
| FCF MarginFCF ÷ Revenue | -7575.0% | +2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.3% | -3.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +33.3% | -163.3% |
Valuation Metrics
ANGI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $6M | $192M |
| Enterprise ValueMkt cap + debt − cash | $5M | $386M |
| Trailing P/EPrice ÷ TTM EPS | -1.41x | 5.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 5.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 3.08x |
| Price / SalesMarket cap ÷ Revenue | 9999.00x | 0.19x |
| Price / BookPrice ÷ Book value/share | 1.26x | 0.24x |
| Price / FCFMarket cap ÷ FCF | — | 4.22x |
Profitability & Efficiency
ANGI leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
ANGI delivers a 2.1% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-83 for MYSE. On the Piotroski fundamental quality scale (0–9), ANGI scores 6/9 vs MYSE's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -83.2% | +2.1% |
| ROA (TTM)Return on assets | -70.0% | +1.2% |
| ROICReturn on invested capital | -90.3% | +5.0% |
| ROCEReturn on capital employed | -97.4% | +5.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 |
| Debt / EquityFinancial leverage | — | 0.54x |
| Net DebtTotal debt minus cash | -$1M | $194M |
| Cash & Equiv.Liquid assets | $1M | $304M |
| Total DebtShort + long-term debt | $0 | $498M |
| Interest CoverageEBIT ÷ Interest expense | -55.49x | 5.38x |
Total Returns (Dividends Reinvested)
MYSE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MYSE five years ago would be worth $591 today (with dividends reinvested), compared to $341 for ANGI. Over the past 12 months, MYSE leads with a -17.9% total return vs ANGI's -57.4%. The 3-year compound annual growth rate (CAGR) favors MYSE at -16.1% vs ANGI's -42.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +12.8% | -62.1% |
| 1-Year ReturnPast 12 months | -17.9% | -57.4% |
| 3-Year ReturnCumulative with dividends | -40.9% | -81.3% |
| 5-Year ReturnCumulative with dividends | -94.1% | -96.6% |
| 10-Year ReturnCumulative with dividends | -94.1% | -94.5% |
| CAGR (3Y)Annualised 3-year return | -16.1% | -42.8% |
Risk & Volatility
Evenly matched — MYSE and ANGI each lead in 1 of 2 comparable metrics.
Risk & Volatility
ANGI is the less volatile stock with a 1.85 beta — it tends to amplify market swings less than MYSE's 2.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MYSE currently trades 35.0% from its 52-week high vs ANGI's 24.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.34x | 1.85x |
| 52-Week HighHighest price in past year | $5.77 | $19.42 |
| 52-Week LowLowest price in past year | $1.31 | $4.53 |
| % of 52W HighCurrent price vs 52-week peak | +35.0% | +24.7% |
| RSI (14)Momentum oscillator 0–100 | 45.3 | 49.6 |
| Avg Volume (50D)Average daily shares traded | 5.0M | 1.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $12.75 |
| # AnalystsCovering analysts | — | 54 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +77.4% |
ANGI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MYSE leads in 1 (Total Returns). 1 tied.
MYSE vs ANGI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MYSE or ANGI a better buy right now?
For growth investors, Angi Inc.
(ANGI) is the stronger pick with -13. 0% revenue growth year-over-year, versus -35. 1% for Myseum Inc. (MYSE). Angi Inc. (ANGI) offers the better valuation at 5. 1x trailing P/E (5. 6x forward), making it the more compelling value choice. Analysts rate Angi Inc. (ANGI) a "Hold" — based on 54 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MYSE or ANGI?
Over the past 5 years, Myseum Inc.
(MYSE) delivered a total return of -94. 1%, compared to -96. 6% for Angi Inc. (ANGI). Over 10 years, the gap is even starker: MYSE returned -94. 1% versus ANGI's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MYSE or ANGI?
By beta (market sensitivity over 5 years), Angi Inc.
(ANGI) is the lower-risk stock at 1. 85β versus Myseum Inc. 's 2. 34β — meaning MYSE is approximately 27% more volatile than ANGI relative to the S&P 500.
04Which is growing faster — MYSE or ANGI?
By revenue growth (latest reported year), Angi Inc.
(ANGI) is pulling ahead at -13. 0% versus -35. 1% for Myseum Inc. (MYSE). On earnings-per-share growth, the picture is similar: Myseum Inc. grew EPS 65. 5% year-over-year, compared to 32. 4% for Angi Inc.. Over a 3-year CAGR, ANGI leads at -16. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MYSE or ANGI?
Angi Inc.
(ANGI) is the more profitable company, earning 4. 3% net margin versus -9722. 8% for Myseum Inc. — meaning it keeps 4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ANGI leads at 7. 6% versus -12112. 2% for MYSE. At the gross margin level — before operating expenses — ANGI leads at 90. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MYSE or ANGI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MYSE or ANGI better for a retirement portfolio?
For long-horizon retirement investors, Angi Inc.
(ANGI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Myseum Inc. (MYSE) carries a higher beta of 2. 34 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ANGI: -94. 5%, MYSE: -94. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MYSE and ANGI?
These companies operate in different sectors (MYSE (Technology) and ANGI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MYSE is a small-cap quality compounder stock; ANGI is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.